Table 4.
PIF |
Phase 1 |
Inspiration |
|
Global ROI |
Ventral ROI
$/§
|
Middle ROI |
Dorsal ROI |
---|---|---|---|---|---|---|---|
PEEP [mbar] | V T /weight [ml/kg] | Lung | n | Mean ± sd [ml/s] | Mean ± sd [ml/s] | Mean ± sd [ml/s] | Mean ± sd [ml/s] |
0 |
15 |
healthy |
7 |
467.27 ± 56.69 |
109.87 ± 15.45 |
317.60 ± 34.38 |
298.54 ± 120.62 |
0 |
20 |
healthy |
7 |
571.94 ± 100.47 |
126.10 ± 17.69 |
345.79 ± 54.36 |
327.13 ± 127.57 |
5 |
15 |
healthy |
7 |
510.92 ± 102.16 |
116.04 ± 14.20 |
324.25 ± 73.59 |
334.11 ± 135.32 |
5 |
20 |
healthy |
7 |
621.80 ± 85.20 |
129.70 ± 16.65 |
396.75 ± 50.78 |
348.89 ± 139.71 |
10 |
15 |
healthy |
7 |
550.89 ± 82.35 |
105.82 ± 13.13 |
335.46 ± 48.16 |
339.63 ± 132.18 |
10 |
20 |
healthy |
7 |
711.67 ± 104.68 |
123.85 ± 22.84 |
424.07 ± 84.16 |
402.98 ± 143.06 |
5 |
15 |
healthy |
6 |
901.90 ± 92.06 |
118.94 ± 32.59 |
512.73 ± 81.67 |
283.00 ± 59.44 |
5 |
15 |
LAV |
6 |
968.55 ± 64.49 |
158.94* ± 24.26 |
602.78* ± 91.51 |
335.89 ± 83.67 |
LIF |
Phase 2 |
Inspiration |
|
Global ROI |
Ventral ROI
$
|
Middle ROI |
Dorsal ROI |
PEEP [mbar] |
V
T
/weight [ml/kg] |
Lung |
n |
Mean ± sd [ml/s] |
Mean ± sd [ml/s] |
Mean ± sd [ml/s] |
Mean ± sd [ml/s] |
0 |
15 |
healthy |
7 |
72.04 ± 16.52 |
10.26 ± 5.27 |
36.77 ± 28.00 |
19.03 ± 4.99 |
0 |
20 |
healthy |
7 |
86.66 ± 36.51 |
10.80 ± 4.08 |
43.22 ± 24.84 |
17.66 ± 4.93 |
5 |
15 |
healthy |
7 |
55.58 ± 23.32 |
5.65 ± 4.35 |
18.02 ± 3.12 |
16.05 ± 4.31 |
5 |
20 |
healthy |
7 |
52.11 ± 10.05 |
9.50 ± 4.76 |
27.59 ± 15.06 |
10.45 ± 5.20 |
10 |
15 |
healthy |
7 |
47.17 ± 16.57 |
7.83 ± 3.67 |
23.31 ± 8.22 |
11.93 ± 9.44 |
10 |
20 |
healthy |
7 |
64.37 ± 45.81 |
8.69 ± 4.00 |
32.91 ± 5.27 |
18.07 ± 15.34 |
5 |
15 |
healthy |
6 |
13.58 ± 2.70 |
4.03 ± 0.52 |
18.55 ± 8.65 |
12.72 ± 5.84 |
5 |
15 |
LAV |
6 |
19.09* ± 5.14 |
2.82 ± 1.83 |
10.74* ± 5.29 |
13.02 ± 3.73 |
PEF |
Phase 3 |
Expiration |
|
Global ROI |
Ventral ROI
$/§
|
Middle ROI |
Dorsal ROI |
PEEP [mbar] |
V
T
/ weight [ml/kg] |
Lung |
n |
Meann ± msd [ml/s] |
Mean ± sd [ml/s] |
Mean ± sd [ml/s] |
Mean ± sd [ml/s] |
0 |
15 |
healthy |
7 |
-587.38 ± 86.73 |
-130.15 ± 21.79 |
-360.79 ± 60.67 |
-344.81 ± 140.78 |
0 |
20 |
healthy |
7 |
-687.01 ± 138.84 |
-141.14 ± 24.29 |
-419.64 ± 68.85 |
-360.89 ± 135.22 |
5 |
15 |
healthy |
7 |
-609.64 ± 164.78 |
-122.24 ± 16.87 |
-359.02 ± 71.82 |
-351.49 ± 156.67 |
5 |
20 |
healthy |
7 |
-675.96 ± 142.03 |
-119.51 ± 20.03 |
-397.41 ± 67.45 |
-413.33 ± 170.68 |
10 |
15 |
healthy |
7 |
-581.72 ± 119.23 |
-107.19 ± 13.15 |
-356.31 ± 53.46 |
-353.22 ± 127.59 |
10 |
20 |
healthy |
7 |
-685.25 ± 114.72 |
-108.40 ± 13.30 |
-395.27 ± 41.11 |
-383.60 ± 152.15 |
5 |
15 |
healthy |
6 |
-666.61 ± 62.94 |
-94.05 ± 12.91 |
-373.52 ± 74.09 |
-257.96 ± 47.51 |
5 |
15 |
LAV |
6 |
-734.43* ± 44.74 |
-130.40* ± 26.63 |
-441.15 ± 102.11 |
-349.22 ± 145.95 |
LEF |
Phase 4 |
Expiration |
|
Global ROI |
Ventral ROI
$
|
Middle ROI
§
|
Dorsal ROI |
PEEP [mbar] |
V
T
/ weight [ml/kg] |
Lung |
n |
Mean ± sd [ml/s] |
Mean ± sd [ml/s] |
Mean ± sd [ml/s] |
Mean ± sd [ml/s] |
0 |
15 |
healthy |
7 |
-40.23 ± 25.65 |
-5.74 ± 4.36 |
-27.25 ± 14.37 |
-7.11 ± 5.85 |
0 |
20 |
healthy |
7 |
-58.85 ± 30.50 |
-8.73 ± 4.94 |
-48.72 ± 19.19 |
-16.04 ± 7.86 |
5 |
15 |
healthy |
7 |
-50.20 ± 17.22 |
-5.41 ± 4.37 |
-27.87 ± 8.07 |
-3.74 ± 1.78 |
5 |
20 |
healthy |
7 |
-62.46 ± 37.63 |
-5.46 ± 2.57 |
-47.50 ± 13.66 |
-16.79 ± 10.81 |
10 |
15 |
healthy |
7 |
-49.84 ± 37.89 |
-3.77 ± 2.04 |
-23.78 ± 22.54 |
-9.10 ± 11.72 |
10 |
20 |
healthy |
7 |
-86.42 ± 27.98 |
-6.67 ± 3.74 |
-51.34 ± 15.72 |
-15.81 ± 5.00 |
5 |
15 |
healthy |
6 |
-39.16 ± 23.89 |
-5.71 ± 3.26 |
-26.44 ± 10.16 |
-8.36 ± 4.09 |
5 | 15 | LAV | 6 | -36.15 ± 27.84 | -6.29 ± 2.20 | -20.37 ± 16.26 | -2.63* ± 1.00 |
PEEP: positive end-expiratory pressure. VT/weight: tidal volume per body weight. sd: standard deviation. LAV: lavage injury. Statistical analysis (two-way ANOVA): *p <0.05: comparison to condition above. ROI analysis: $p < 0.05 comparison to middle ROI, §p < 0.05 comparison to dorsal ROI.